LUNGevity Foundation is proud to honor Dr. Lecia Sequist as LUNGevity Hero for the month of November, kicking off Lung Cancer Awareness Month. Her extraordinary contributions to lung cancer research in the fields of genetic mutations and drug resistance have changed the way we look at lung cancer. A triple threat oncologist, she dedicates time to 15-20 lung clinical trials at any given time while also practicing medicine at Massachusetts General Hospital Cancer Center and serving as an assistant professor at Harvard Medical School. And she does not stop there. Dr. Sequist is a constant advocate for the lung cancer community, speaking out about lung cancer on behalf of those who cannot. She is the perfect Hero for Lung Cancer Awareness Month, serving as a strong voice for the research community and taking initiative to better the lives of her patients and the greater lung cancer community.
Her team is responsible for several remarkable findings in lung cancer genomics, including the discovery that the type of lung cancer that patients display at diagnosis may evolve into another type of lung cancer after treatment. The study has informed the process of lung cancer treatment, ensuring the best treatment choices are made for the cancer at its present stage and type. Her current research project will help us better understand the development of drug resistance, which tends to occur after about a year of drug use.
Dr. Sequist is dedicated to sharing her knowledge with those diagnosed with lung cancer. She speaks about the importance of mutational testing, which can open a whole world of targeted therapies to lung cancer patients, and about the disease in general, reminding the general population that it can affect anyone regardless of age, gender, and smoking history. She was recently featured in Self Magazine, identifying the gap in funding between different diseases and how that affects the scientific progress for research. She remarks on the remarkable progress our scientific community has made in finding treatments for lung cancer in the last several years, and she is energized about what the next few years hold for the research field.
“Naming Dr. Sequist as the November LUNGevity Hero is the perfect beginning to Lung Cancer Awareness Month,” said Andrea Ferris, president and chairman of LUNGevity Foundation. “Her research is changing the way we view and treat lung cancer, and her voice is changing the lung cancer paradigm of the world we live in every day, for researchers and for patients.”